Head of Strategic Assets & GENERAL COUNSEL
Holly joined Drawbridge Health in 2019 and brings nearly 20 years of legal experience in the life science, diagnostic and medical device industries.
Prior to joining Drawbridge Health, Holly developed intellectual property portfolios and served as commercial and IP counsel to several companies, including BioTheranostics, Trovagene, Gensignia, GenSpera and Aktana. Holly also developed a wealth of experience across several areas of law, including commercial transactions, litigation and regulatory compliance, as an attorney at Arnold & Porter, LLP and as Professional Staff at the U.S. House of Representatives.
Holly received her BS in Biochemistry and her JD from the University of Michigan, and received her MBA from Wharton at the University of Pennsylvania.